Sanjiv Agarwala, MD, is the chief of medical oncology and hematology at St. Luke’s Cancer Center and professor of medicine at Temple University School of Medicine, in Philadelphia, PA. Dr. Agarwala is nationally and internationally recognized as an expert in the research and treatment of melanoma and immunotherapy of cancer and has presented and led numerous conferences and meetings across the globe.
Dr. Agarwala received his undergraduate education and medical degree from Bombay University. He completed his medical training through residencies and fellowships at the University of Bombay in India, Otago University in New Zealand and the University of Pittsburgh in Pennsylvania.
Dr. Agarwala has written and contributed to over 200 publications and book chapters on melanoma, immune-oncology and other research areas. He is board certified in oncology and hematology and is as an active member of several professional and scientific societies, such as the American Association for Cancer Research, the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Society for Melanoma Research.
Dr. Agarwala has been principal investigator for multiple clinical trials involving immunotherapy and targeted therapy for melanoma, renal cancer and other malignancies. He has received several honors, including listings as one of America’s top doctors for cancer and best doctors in the United States.
Updated Medical Treatment for Melanoma
- Update on new information and studies
- Update on new therapies
- New detection techniques
- New advances in dermatologic treatment
- New methods of diagnosis or treatment
- Development of new technology
- Macbeth F, Newton-Bishop J, O’Connell S, Hawkins JE; Guideline Development Group. BMJ. 2015 Jul 29;351:h3708. doi: 10.1136/bmj.h3708.
- Bichakjian et al, Guidelines of Care for the Management of Primary Cutaneous Melanoma, JAAD V65N5; 1032-1047.
Core Competencies: 2, 3, 6
Case Studies in Melanoma: An Interactive Panel
This lecture will be an interactive discussion of complex melanoma patients with a panel of experts and the attendees.
Review and discuss of complex melanoma patients from a diagnostic standpoint
Review and discuss treatment alternatives in treating complex melanoma patients
Invite audience participation through discuss of complex cases from the practice
New advances in dermatologic treatment
New methods of diagnosis or treatment
Availability of new medication(s) or indication(s)
M.B. Faries, et al. “Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.” N Engl J Med, 2017 June 8; 376(23): 2211-2281.
NCCN Clinical Practice Guidelines in Oncology. “Melanoma”. 2016, Nov 10; Version 1.2017. www.nccn.org/patients.
Core competencies: 2, 3, 4, 6
Disclosures: No disclosures provided by speaker